August 10, 2026

FDA Approves Melanoma BRAF Companion Test

The assay is indicated to identify patients with advanced melanoma who have BRAF V600E or BRAF V600K variants and may benefit from FDA-approved targeted therapies.

MDSpire News

August 07, 2026

SCCA May Aid Pulmonary SCC Diagno­sis

The biomarker showed its strongest diagnostic performance in pulmonary squamous cell carcinoma but also rose in inflammatory lung diseases, underscoring its role as an adjunct rather than a stand‐alone test.

MDSpire News

August 03, 2026

FDA Approves Pluvicto for Hormone-Sensitive Prostate Cancer

The approval is based on phase 3 PSMAddition results showing reduced risk of disease progression or death with Pluvicto plus standard of care compared with standard of care alone, according to Novartis.

MDSpire News

July 31, 2026

Postsurgical Ensartinib in ALK-Positive NSCLC

Adjuvant ensartinib may represent a new therapeutic strategy in completely resected disease.

MDSpire News

July 27, 2026

Colorectal Cancer Screening Blood Test Approved by FDA

The blood-based assay demonstrated 81% sensitivity for colorectal cancer in the PREEMPT CRC study.

MDSpire News

July 22, 2026

CLDN18.2 May Define Lung Adenocarcinoma Phenotype

Frequent CLDN18.2 expression was associated with gastric-type differentiation and reduced spread through air spaces in pulmonary invasive mucinous adenocarcinoma.

MDSpire News

July 20, 2026

Narrow DCIS Margins May Not Always Warrant Reexcision

An ancillary analysis found less than 2-percentage-point differences in 10-year recurrence across margin thresholds, with no statistically significant adjusted association.

MDSpire News

July 14, 2026

FDA Expands Test for Gastric and Esophageal Cancers

According to Agilent Technologies, the expanded indication covers esophageal and gastric tumor types and applies to patients being considered for nivolumab or nivolumab and hyaluronidase-nvhy.

MDSpire News

July 07, 2026

Medical Oddities: When a Brush Beats a Scalpel

This research roundup has brain drama, bleeding control, skin science, and tiny brushes.

MDSpire News

July 02, 2026

Does Structured Reporting Improve Lung Cancer Reports?

A structured reporting tool improved report completeness, reduced classification errors, and achieved high physician adoption during routine lung cancer pathology reporting.

MDSpire News